Type 2 diabetes trials in Netherlands
23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Amsterdam, Nijmegen, Rotterdam, Utrecht, Zwolle
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Amersfoort, Amsterdam, Arnhem, Beek Lb, Beverwijk, Delft, Eindhoven, Emmen, Goes, Groningen, Hilversum, Hoogeveen, Maastricht, Nijmegen, 's-Hertogenbosch, 'S-Hertogenbosch, Sneek, Stadskanaal, Utrecht, Zwolle
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 1/2Taking peopleThe RJVA-001 First in Human Trial in Adults with Inadequately Controlled Type 2 Diabetes.
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 15
- Run by
- Fractyl Health Inc.
See details and how to join2025-524438-24-00 · EU 2025-524438-24-00 - Phase 3Taking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Arnhem, Born, Hoofddorp, Hoogeveen, Rotterdam, 's-Gravenhage, 's-Hertogenbosch
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseTaking peopleA Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes
- Where
- Eindhoven
- Age
- 18 years and over
- People
- 30
- Run by
- Maxima Medical Center
See details and how to joinNCT07812623 - Phase 1Taking peopleA Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
- Where
- Groningen
- Age
- 18 years to 75 years
- People
- 114
- Run by
- AC Immune SA
See details and how to joinNCT07463196 · EU 2025-523885-25-00 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Leiden
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - No phaseTaking peopleForearm Immobilization in T2D
- Where
- Wageningen
- Age
- 18 years to 80 years
- People
- 26
- Run by
- Wageningen University
See details and how to joinNCT06750497 - No phaseNot yet taking people in NetherlandsAn Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.
- Where
- Enschede
- Age
- 18 years and over
- People
- 160
- Run by
- University of Twente
See details and how to joinNCT07661381 - No phaseNot yet taking people in NetherlandsSweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 80
- Run by
- Erasmus Medical Center
See details and how to joinNCT07587918 - Phase 4Taking peopleRole of BCAA in glucose homeostasis
- Where
- Maastricht
- Age
- 18 years and over
- People
- 26
- Run by
- Maastricht University
See details and how to join2023-503424-12-00 · EU 2023-503424-12-00 - Phase 4Enrolling by invitationEffect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
- Where
- Rotterdam
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Carmen Dietvorst
See details and how to joinNCT06845345 · EU 2024-519774-40-00 - No phaseTaking peopleTargeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases
- Where
- Maastricht, Wageningen
- Age
- 40 years to 75 years
- People
- 240
- Run by
- Maastricht University Medical Center
See details and how to joinNCT06923644 - No phaseTaking peopleEvaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 1,000
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07237685 - No phaseNot yet taking people in NetherlandsRAPIDE: The Feasibility of a Hybrid Care Model
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Radboud University Medical Center
See details and how to joinNCT06735404 - Phase 4Taking peopleDiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
- Where
- Amsterdam
- Age
- 18 years to 85 years
- People
- 34 worldwide
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06983054 · EU 2023-510257-42-01 - No phaseEnrolling by invitationCheck@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease
- Where
- Amsterdam
- Age
- 50 years to 75 years
- People
- 320,000
- Run by
- Prof. Dr. Folkert W. Asselbergs
See details and how to joinNCT06330480 - No phaseTaking peoplePostoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 1,008
- Run by
- Abraham Hulst, MD, PhD
See details and how to joinNCT06638567 - No phaseTaking peopleGlobal Research Initiative for Patients Screening on MASH
- Where
- Amsterdam, Rotterdam
- Age
- 18 years to 75 years
- People
- 10,000 worldwide
- Run by
- Julius Clinical
See details and how to joinNCT05651724 - Phase 4Taking peopleNT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
- Where
- Maastricht
- Age
- 18 years and over
- People
- 2,400 worldwide
- Run by
- Martin Huelsmann
See details and how to joinNCT02817360 · EU 2024-519051-28-01 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Amsterdam
- Age
- 18 years to 100 years
- People
- 10,000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleEuropean Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
- Where
- Maastricht
- Age
- Up to 18 years
- People
- 2,000 worldwide
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT04190849